Jennifer Newberger Returns to HPM as a Director After Stints with Apple, Abbott Laboratories, and Cognito Therapeutics
FDA Law Blog
MAY 27, 2024
Jennifer’s return adds depth and breadth to our device practice and her strong relationships from her earlier time at the firm has made for a seamless reentry,” said J.P. With her return to the firm, she can now utilize her recent in-house experience to help HPM’s diverse client base solve complex problems.
Let's personalize your content